Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes
- PMID: 30391805
- PMCID: PMC6278951
- DOI: 10.1016/j.jpsychires.2018.10.020
Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes
Abstract
Preclinical studies implicate insulin signaling as a modulator of dopamine transmission, but human data is currently limited. We hypothesize that changes in the expression of insulin receptor-related genes in the post-mortem brain tissue of patients with mood and psychotic disorders mediate the expression of dopamine regulation-related genes. From a database containing microarray data from the post-mortem dorsolateral prefrontal cortex (dlPFC) (healthy controls [HC]: n = 209; patients: n = 321) and hippocampus (HC: n = 180; patients: n = 196), we conducted a hypothesis-driven analysis through the a priori selection of 12 dopamine- and 3 insulin-related genes. Mediation and moderated mediation models, accounting for the role of body mass index (BMI), were used. In the dlPFC, expressions of insulin receptor- and dopamine regulation-related genes were moderated by BMI, with significantly lower expression in high BMI patients. In the hippocampus, there were significantly lower expressions of these genes, which were not moderated by BMI. Illnesses by BMI effects on expression of dopamine genes were fully mediated by expression of insulin receptor gene (INSR). Analysis of conditional indirect effects showed interactions between INSR and BMI, indicating significantly stronger indirect effects at higher BMI values. In the hippocampus we observed that expression of insulin receptor substrate 1 and 2 fully mediated the effects of illnesses on expression of dopamine genes. In conclusion, differential expression of dopamine-related genes was related to altered expression of insulin signaling genes. BMI had region-specific effects, supporting the hypothesis that metabolic systems are critical mediators of dopaminergic function.
Trial registration: ClinicalTrials.gov NCT00001260.
Keywords: Dopamine; Gene expression; Insulin; Mood disorders; Schizophrenia.
Copyright © 2018. Published by Elsevier Ltd.
Figures

Similar articles
-
The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders.Eur Neuropsychopharmacol. 2019 Jan;29(1):137-146. doi: 10.1016/j.euroneuro.2018.10.007. Epub 2018 Nov 6. Eur Neuropsychopharmacol. 2019. PMID: 30409537 Free PMC article.
-
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.Transl Psychiatry. 2019 May 23;9(1):151. doi: 10.1038/s41398-019-0492-8. Transl Psychiatry. 2019. PMID: 31123247 Free PMC article.
-
The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.J Psychiatr Res. 2018 Jul;102:186-191. doi: 10.1016/j.jpsychires.2018.04.012. Epub 2018 Apr 13. J Psychiatr Res. 2018. PMID: 29680575
-
Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder.Psychiatry Res. 2019 Oct;280:112503. doi: 10.1016/j.psychres.2019.112503. Epub 2019 Jul 31. Psychiatry Res. 2019. PMID: 31446215
-
The impact of sex on gene expression in the brain of schizophrenic patients: a systematic review and meta-analysis of transcriptomic studies.Biol Sex Differ. 2024 Jul 27;15(1):59. doi: 10.1186/s13293-024-00635-x. Biol Sex Differ. 2024. PMID: 39068467 Free PMC article.
Cited by
-
Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study.Front Pharmacol. 2023 Nov 9;14:1264591. doi: 10.3389/fphar.2023.1264591. eCollection 2023. Front Pharmacol. 2023. PMID: 38026922 Free PMC article.
-
Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes.Front Psychiatry. 2019 Feb 14;10:57. doi: 10.3389/fpsyt.2019.00057. eCollection 2019. Front Psychiatry. 2019. PMID: 30837902 Free PMC article. Review.
-
Insulin action in the brain regulates both central and peripheral functions.Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E156-E163. doi: 10.1152/ajpendo.00642.2020. Epub 2021 May 31. Am J Physiol Endocrinol Metab. 2021. PMID: 34056920 Free PMC article. Review.
-
Antidepressants and type 2 diabetes: highways to knowns and unknowns.Diabetol Metab Syndr. 2023 Aug 31;15(1):179. doi: 10.1186/s13098-023-01149-z. Diabetol Metab Syndr. 2023. PMID: 37653558 Free PMC article. Review.
-
Interaction between baseline BMI and baseline disease severity predicts greater improvement in negative symptoms in first-episode schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2024 Sep;274(6):1327-1332. doi: 10.1007/s00406-024-01763-6. Epub 2024 Mar 27. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38536473
References
-
- Anand A, Barkay G, Dzemidzic M, Albrecht D, Karne H, Zheng QH, et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011;13:406–13. - PubMed
-
- Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182–217. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous